Regenxbio Inc. faces pivotal catalysts in 2026, notably RGX-121's FDA decision and RGX-202 Duchenne data, potentially ...

Picture CRISPR-Cas9, a gene editing technology, as a GPS-guided scalpel: gRNA directs the Cas9 enzyme, a protein that cuts ...

The specifics of endoscopic/surgical resection and perioperative treatment ...

A team at Japan's National Institutes for Quantum Science and Technology (QST) has published a field-defining Perspective ...

In a case that reads like a mashup of Seabiscuit and Breaking Bad, a New Mexico judge stepped in last month to block the ...

Once upon a time, India’s billionaires wore safari suits or pinstripes—men who built empires, not apps in dorm rooms. Wealth ...

Pam Kowalcyzk and her daughter have PKU, a rare disorder that prevents the body from processing protein ...

The latest update on Ginkgo Bioworks Holdings has reset its fair value anchor from US$12.00 to US$10.00, reflecting a more cautious stance on the stock's long term potential. This comes alongside a ...

I reassured him and sent him to get another blood specimen drawn without a tourniquet. Why? Because I suspected that the ...

Shares of Amicus Therapeutics FOLD have witnessed a strong surge in the past six months, primarily driven by the growing ...

If you were hung over on New Year’s Day, and decided to take it easy by reading the Wall Street Journal’s deep dive into Donald Trump’s aging and health, one item no doubt stood out, because it was so ...

JCR Pharmaceuticals announced that it will present data at the 22nd Annual WORLDSymposium 2026, held February 2-6, 2026, in San Diego, Calif.